Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04577755 · ClinicalTrials.gov registry record · Phase 2
Pomalidomide Treatment in Patients With Kaposi Sarcoma
A Phase 2 study of Skin Kaposi Sarcoma, sponsored by National Cancer Institute (NCI).
- Active
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
- 15
- Study locations
NCT04577755 is a Phase 2 study of Skin Kaposi Sarcoma that is active but no longer recruiting, run by National Cancer Institute (NCI). The registered enrollment target is 45 participants. The trial reports 15 study locations across 11 states.
The verdict
NCT04577755, a Phase 2 study of Skin Kaposi Sarcoma, is active but no longer recruiting, sponsored by National Cancer Institute (NCI).
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
- 15
- Study locations
Study Summary
This phase II trial studies the effect of pomalidomide in treating patients with Kaposi sarcoma. Pomalidomide is a cancer fighting drug that stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- PROCEDURE Computed Tomography
- PROCEDURE Biopsy Procedure
- PROCEDURE X-Ray Imaging
- DRUG Pomalidomide
Study Locations (15)
New York
- Mount Sinai Hospital - New York
- NYP/Weill Cornell Medical Center - New York
- Montefiore Medical Center-Einstein Campus - The Bronx
Pennsylvania
- University of Pennsylvania/Abramson Cancer Center - Philadelphia
- Pennsylvania Hospital - Philadelphia
Texas
- Thomas Street at Quentin Mease Health Center - Houston
- M D Anderson Cancer Center - Houston
California
- UC San Diego Moores Cancer Center - La Jolla
Florida
- Miami Cancer Institute - Miami
Illinois
- University of Illinois - Chicago
Maryland
- Johns Hopkins University/Sidney Kimmel Cancer Center - Baltimore
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-03-18 |
| Est. Completion | 2026-10-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04577755
The ClinicalTrials.gov registry entry for NCT04577755 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Kaposi Sarcoma appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT04577755 reports 15 study locations spanning 11 distinct geographic areas - top geographies include New York, Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT04577755 about?
NCT04577755 is a clinical study titled "Pomalidomide Treatment in Patients With Kaposi Sarcoma". This phase II trial studies the effect of pomalidomide in treating patients with Kaposi sarcoma. Pomalidomide is a cancer fighting drug that stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells.
What is the current status of trial NCT04577755?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2022-03-18. Estimated completion is 2026-10-01.
What conditions does trial NCT04577755 study?
This clinical trial studies the following conditions: Skin Kaposi Sarcoma.
What interventions are being tested in trial NCT04577755?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Computed Tomography (PROCEDURE), Biopsy Procedure (PROCEDURE), X-Ray Imaging (PROCEDURE), Pomalidomide (DRUG).
Who is sponsoring clinical trial NCT04577755?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04577755 being conducted?
This trial has 15 study locations across California, Florida, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.